InspireMD has announced that it has received approval from the U.S. Food and Drug Administration (FDA) to commence a study involving its stroke device. This approval marks a significant step in the company's efforts to advance its medical technology aimed at improving outcomes for stroke patients. The study will evaluate the safety and efficacy of the device, which is designed to address critical needs in stroke intervention. InspireMD is now positioned to initiate the clinical trial as part of its commitment to innovation in healthcare.
Related Articles
Don't miss out on breaking stories and in-depth articles.